Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma

BackgroundRibonucleotide reductase regulatory subunit M2 (RRM2) has been reported to be an oncogene in some malignant tumors, such as lung adenocarcinoma, oral squamous cell carcinoma, glioblastoma, and breast cancer. However, the clinical significance of RRM2 in hepatocellular carcinoma has been le...

Full description

Bibliographic Details
Main Authors: Zhongqiang Qin, Bo Xie, Jingyu Qian, Xiang Ma, Lan Zhang, Jianzhu Wei, Zhaoying Wang, Longfei Fan, Ziyi Zhu, Zhen Qian, Hongxiang Yin, Fangquan Zhu, Yulin Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
ribonucleotide reductase regulatory subunit M2
hepatocellular carcinoma
bioinformatics analysis
biomarker
The Cancer Genome Atlas
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1144269/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1144269/full

Similar Items